Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Anu
Anu Ajithkumar, Neuchatel CH
| Patent application number | Description | Published |
|---|---|---|
| 20120006343 | AEROSOL-GENERATING SUBSTRATE FOR SMOKING ARTICLES - Strands of homogenized tobacco material include at least one aerosol former, An aerosol-generating substrate includes a plurality of those strands of homogenized tobacco material. A smoking article may further include the aerosol-generating substrate. Those strands of homogenized tobacco material preferably have a mass-to-surface-area ratio of at least about 0.09 mg/mm | 01-12-2012 |
Anu Appaji, Plano, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080267101 | Universal Browser - A method, a computer readable medium and a system for universal browsing that comprises, sending a request for a service by a mobile terminal to a service portal, determining a protocol needed to fulfill the request by the service portal, if the protocol needed is resident on the mobile terminal, determining a sensor that can fulfill the request, sending the request by the service portal to the sensor, establishing a connection between the mobile terminal and the sensor, and sending a response to the request to the mobile terminal via the connection. | 10-30-2008 |
Anu Hopia, Helsinki FI
| Patent application number | Description | Published |
|---|---|---|
| 20100298261 | EDIBLE COMPOSITIONS FOR LOWERING CHOLESTEROL - The present invention is related to improved compositions for reducing serum total and/or LDL cholesterol levels. The compositions are combinations of dietary fibre and plant sterol. The compositions are used as such or more advantageously in food products and comprise one or several fibres, preferably β-glucan, in combination with one or several plant sterols and/or stanols in their free and/or esterified forms. | 11-25-2010 |
Anu Kaukovirta-Norja, Espoo FI
| Patent application number | Description | Published |
|---|---|---|
| 20100092651 | METHOD FOR FRACTIONATING OAT, PRODUCTS THUS OBTAINED, AND USE THEREOF - The invention relates to a method of preparing functionally valuable products, such as β-glucan, protein, starch and lipid concentrates from oat. The invention also relates to products thus obtained and to the use thereof. The invention further relates to the use of non-heat-treated or slightly heat-treated oat fat-extracted with supercritical extraction for preparing said products by using dry milling, sieving and air classification. | 04-15-2010 |
| 20110009613 | METHOD OF PROCESSING BETA-GLUCAN - The invention relates to a method of degrading plant-based β-glucan into a controlled molecular size by hydrolyzing β-glucan in a closed space under pressure by means of an acid at an elevated temperature. The invention also relates to a degraded β-glucan product. The β-glucan product obtained is useful in foodstuffs applications, such as beverages. | 01-13-2011 |
Anu Launiainen, Pirkkala FI
| Patent application number | Description | Published |
|---|---|---|
| 20090021377 | Tamperproof tag - A tag including a substrate bordered by an outer edge and an inner circular edge. The substrate has a face side and a reverse side. An arrangement includes an antenna and an integrated circuit on a chip on the reverse side of the substrate. The integrated circuit on the chip is electrically connected to the antenna. An adhesive on the reverse side of the substrate covers the arrangement. A part of the arrangement has a greater adhesion to the adhesive than to the substrate. First cuts extend radially from the inner circular edge. Second cuts extend parallel to the first cuts from the outer edge. A region without cuts between the first cuts and the second cuts. | 01-22-2009 |
Anu Lokkiluoto, Helsinki FI
| Patent application number | Description | Published |
|---|---|---|
| 20120067740 | METHOD FOR CONCENTRATING DILUTE SULFURIC ACID AND AN APPARATUS FOR CONCENTRATING DILUTE SULFURIC ACID - A method for concentrating dilute sulfuric acid involves feeding dilute sulfuric acid through at least two electrolytic cells depolarized by sulfur dioxide, and through a cation conductive membrane separating the cathode and anode sides in the electrolytic cell. Also provided is an apparatus for concentrating sulfuric acid, wherein at least a first electrolytic cell is in fluid communication with a second electrolytic cell, and wherein a cation conductive membrane separates the cathode and anode sides in the electrolytic cells. | 03-22-2012 |
Anu Närhi, Karjenniemi FI
| Patent application number | Description | Published |
|---|---|---|
| 20100261006 | RELEASE PRODUCT - A release product including a basic substrate and a siliconized release layer. The basic substrate has a first side and a second side. The siliconized release layer has been applied on the first side of the basic substrate. The release product includes a coating layer which has been applied directly on either the first side of the basic substrate, or the second side of the basic substrate. The coating layer includes silica particles and a binder. | 10-14-2010 |
Anu Närhi, Karjenniemi FI
| Patent application number | Description | Published |
|---|---|---|
| 20100261006 | RELEASE PRODUCT - A release product including a basic substrate and a siliconized release layer. The basic substrate has a first side and a second side. The siliconized release layer has been applied on the first side of the basic substrate. The release product includes a coating layer which has been applied directly on either the first side of the basic substrate, or the second side of the basic substrate. The coating layer includes silica particles and a binder. | 10-14-2010 |
Anu Pathria, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090094064 | Healthcare Insurance Claim Fraud and Error Detection Using Co-Occurrence - A healthcare insurance claim that includes variables characterizing aspects of a healthcare service for which reimbursement is sought is analyzed in order to determine whether there are any aspects that are indicative of fraud or error. This analysis includes generating score variables from the variables of the healthcare insurance claim and determining whether a presence of one or more of the pairs of variables is indicative of fraud or error based on levels of co-occurrence of the one or more pairs in historical healthcare insurance claims. If a positive determination occurs, then the healthcare insurance claim can be flagged or elevated for review by a user. Related techniques, apparatus, systems, and articles are also described. | 04-09-2009 |
Anu Punnoose, Wurzburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110017944 | Method for Encapsulating Latent Heat Storage Material and Products Obtained Thereby - The invention relates to a method for producing an inorganic latent heat storage material that is surrounded by an encapsulating layer that is made of an inorganic-organic polymer material that comprises a metal and/or semi-metal oxygen network with embedded organic groups. The method is characterised in that a liquid or liquefied latent heat storage material, in the form of discrete units that are to be, respectively, encapsulated, is introduced into a liquid or viscous precursor material of the encapsulating material such that the encapsulating material solidifies when coming into contact with the outer surfaces of said latent heat storage material. The invention also relates to an inorganic latent heat storage material that is surrounded by an encapsulating layer and is present in said encapsulation, said encapsulating material being made of an inorganic-organic polymer material that comprises a (semi) metal oxygen network with embedded organic groups, connected, preferably at least partially to (semi) metal. Silane resins are well suited as precursor material. | 01-27-2011 |
Anu Sadasiva, Maple Grove, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080312645 | Vascular Sealing Device and Method Using Clot Enhancing Balloon and Electric Field Generation - An apparatus and method for closing an opening in a blood vessel wall is disclosed. The apparatus includes at least one member which is extended through a tissue tract formed through the epidermis and subcutaneous layer of skin and through the opening in the blood vessel. The member includes a proximal end and a distal end with the distal end being positionable proximate to the opening in the blood vessel wall. A positive electrode is positioned next to the distal end with a negative electrode being positioned next to the proximal end When the electrodes are energized an electric field is created therebetween, blood cells are attracted to the positive electrode, and a thrombus is formed at the opening in the blood vessel wall. The member may include a balloon at the distal end to temporarily occlude blood flow from the blood vessel to the tissue tract to facilitate formation of the thrombus. In addition, the shape of the balloon may be tailored to facilitate the formation of the thrombus including, but not limited to, the creation of pockets and self-supporting balloons | 12-18-2008 |
| 20080312667 | Self-Orientating Suture Wound Closure Device - A device is disclosed for providing an indication as to the relative position of a vessel or artery opening thereby facilitating the choice of which suturing or plugging technique to thereafter use. A disclosed device includes an outer tube and a collapsible foot slidably disposed within a distal end of the outer tube. The foot is connected to a shaft that passes through the tube and exits a proximal end thereof. The device may further include one or more threaded suture needles, a biodegradable plug or other wound closing device that is connected to another shaft. The collapsed or folded foot is pushed distally out of the tube and through the opening in the vessel whereupon the foot expands. Pulling the expanded foot in the proximal direction provides an indication as to the orientation of the opening in the vessel, which assists in determining the type of closing procedure to be carried out. The shaft connected to the foot is preferably connected to an indicator that indicates to the operator or physician that the vessel opening is in one of three positions on the vessel—left, top or right. As an alternative, the indicator bar may indicate a relative position in degrees, mm or μm in deviation from a top stick (or top position). | 12-18-2008 |
| 20080312683 | Apparatus and Method for Closing an Opening in a Blood Vessel Using Memory Metal and Collagen - An apparatus and method for closing an arteriotomy site are disclosed. The apparatus and method employ the use of a delivery sheath within which is provided an anchoring device formed of memory metal. The delivery sheath can be inserted through a tissue tract extending from an epidermal layer to the blood vessel wall, whereupon the anchoring device can be extended from the delivery sheath into the blood vessel itself The memory metal, once freed from the delivery sheath, obtains a non-linear or coiled configuration which can then be pulled back against the inner surface of the blood vessel to form a backstop. A biodegradable plug is then introduced into the tissue tract until it engages the backstop formed by the anchoring device thereby ensuring proper positioning of the biodegradable plug. The anchoring device can then be retracted through the biodegradable plug leaving the arteriotomy site substantially closed with hemostasis being formed therearound The various biodegradable plugs disclosed provide for improved retention of the biodegradable plug and proper positioning of the plug within the tissue tract. | 12-18-2008 |
Anu Sadisiva, Maple Grove, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20080312684 | Apparatus and Method for Closing an Opening in a Blood Vessel Using a Permanent Implant - An apparatus and method for closing an arteriotomy site is disclosed. The apparatus includes inner and outer frames adapted to sandwich a blood vessel wall therebetween. The inner and outer frames may be manufactured from memory metals such that they can be compressed during the insertion into the tissue tract proximate the arteriotomy site, and then deployed into an expanded configuration larger than the dimensions of the arteriotomy opening itself. A universal joint connects the inner and outer frames to ensure proper pivoting therebetween. In addition, polymeric coverings can be provided on the inner and outer frames to ensure closure, while a collagen plug can also be provided between inner and outer frames to facilitate closure as well. | 12-18-2008 |
Anu Sharma, El Cerrito, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090258016 | Substituted imidazole derivatives - The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula: | 10-15-2009 |
| 20100280006 | 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling - Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R. | 11-04-2010 |
Anu Wallecha, Yardley, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110129499 | DUAL DELIVERY SYSTEM FOR HETEROLOGOUS ANTIGENS - Provided herein are recombinant | 06-02-2011 |
Anu Wartiovaara, Helsinki FI
| Patent application number | Description | Published |
|---|---|---|
| 20120064091 | DYSFUNCTION OF THE MITOCHONDRIAL RESPIRATORY CHAIN, METHODS FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP - The invention relates to a method, of assessing whether a subject is affected with or at risk for developing a dysfunction of the mitochondrial respiratory chain, the method comprising determining the concentration of fibroblast growth factor 21 (FGF21) in a biological sample from the subject, and comparing it to the concentration of FGF21 in a biological sample from at least one normal control, wherein an increase in the concentration of FGF21 in the biological sample from the subject when compared to the concentration of FGF21 in the biological sample from at least one normal control is indicative of occurrence of the dysfunction of the mitochondrial respiratory chain in said subject, or of risk for developing said dysfunction. The invention also relates to a method for follow-up of a dysfunction of the mitochondrial respiratory chain in a subject diagnosed with but not being treated for said dysfunction, to a method for treating a subject having a dysfunction of the mitochondrial respiratory chain, to a method for determining whether a dysfunction of the mitochondrial respiratory chain in a subject diagnosed with and being treated for said dysfunction is responding to the treatment, and for selecting patients for clinical trials. | 03-15-2012 |